Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/31916
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Halkett, Georgia K B | - |
dc.contributor.author | Breen, Lauren J | - |
dc.contributor.author | Berg, Melissa | - |
dc.contributor.author | Sampson, Rebecca | - |
dc.contributor.author | Sim, Hao-Wen | - |
dc.contributor.author | Gan, Hui K | - |
dc.contributor.author | Kong, Benjamin Y | - |
dc.contributor.author | Nowak, Anna K | - |
dc.contributor.author | Day, Bryan W | - |
dc.contributor.author | Harrup, Rosemary | - |
dc.contributor.author | James, Melissa | - |
dc.contributor.author | Saran, Frank | - |
dc.contributor.author | Mcfarlane, Brett | - |
dc.contributor.author | Tse, Chris | - |
dc.contributor.author | Koh, Eng-Siew | - |
dc.date | 2022 | - |
dc.date.accessioned | 2023-01-12T05:14:27Z | - |
dc.date.available | 2023-01-12T05:14:27Z | - |
dc.date.issued | 2022-12-17 | - |
dc.identifier.citation | Current Oncology 2022; 29(12) | en_US |
dc.identifier.issn | 1718-7729 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/31916 | - |
dc.description.abstract | The aim of this project was to determine research priorities, barriers, and enablers for adult primary brain tumour research in Australia and New Zealand. Consumers, health professionals, and researchers were invited to participate in a two-phase modified Delphi study. Phase 1 comprised an initial online survey (n = 91) and then focus groups (n = 29) which identified 60 key research topics, 26 barriers, and 32 enablers. Phase 2 comprised two online surveys to (1) reduce the list to 37 research priorities which achieved consensus (>75% 2-point agreement) and had high mean importance ratings (n = 116 participants) and (2) determine the most important priorities, barriers, and enablers (n = 90 participants). The top ten ranked research priorities for the overall sample and sub-groups (consumers, health professionals, and researchers) were identified. Priorities focused on: tumour biology, pre-clinical research, clinical and translational research, and supportive care. Variations were seen between sub-groups. The top ten barriers to conducting brain tumour research related to funding and resources, accessibility and awareness of research, collaboration, and process. The top ten research enablers were funding and resources, collaboration, and workforce. The broad list of research priorities identified by this Delphi study, together with how consumers, health professionals, and researchers prioritised items differently, and provides an evidence-based research agenda for brain tumour research that is needed across a wide range of areas. | en_US |
dc.language.iso | eng | - |
dc.subject | brain tumours | en_US |
dc.subject | consumers | en_US |
dc.subject | delphi | en_US |
dc.subject | research barriers | en_US |
dc.subject | research enablers | en_US |
dc.subject | research priorities | en_US |
dc.title | Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and Researchers. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Current oncology (Toronto, Ont.) | en_US |
dc.identifier.affiliation | Curtin School of Nursing/Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Bentley, WA 6102, Australia. | en_US |
dc.identifier.affiliation | Curtin School of Population Health/Curtin enAble Institute, Faculty of Health Sciences, Curtin University, Bentley, WA 6102, Australia. | en_US |
dc.identifier.affiliation | Curtin School of Nursing/Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Bentley, WA 6102, Australia. | en_US |
dc.identifier.affiliation | Curtin School of Nursing/Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Bentley, WA 6102, Australia. | en_US |
dc.identifier.affiliation | NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW 2050, Australia. | en_US |
dc.identifier.affiliation | Cancer Therapies and Biology Group, Centre of Research Excellence in Brain Tumours, Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, VIC 3084, Australia. | en_US |
dc.identifier.affiliation | NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW 2050, Australia. | en_US |
dc.identifier.affiliation | Medical School, University of Western Australia, Nedlands, WA 6009, Australia. | en_US |
dc.identifier.affiliation | QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia. | en_US |
dc.identifier.affiliation | Royal Hobart Hospital, Hobart, TAS 7000, Australia. | en_US |
dc.identifier.affiliation | Canterbury Regional Cancer and Haematology Service, Christchurch 8011, New Zealand. | en_US |
dc.identifier.affiliation | Department of Blood and Cancer, Auckland City Hospital, Auckland 1023, New Zealand. | en_US |
dc.identifier.affiliation | Cooperative Trials Group for Neuro-Oncology (COGNO), Camperdown, NSW 2050, Australia. | en_US |
dc.identifier.affiliation | Brain Tumour Support NZ, Hamilton 3210, New Zealand. | en_US |
dc.identifier.affiliation | South West Sydney Clinical School, UNSW Medicine, University of New South Wales, Liverpool, NSW 2170, Australia. | en_US |
dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute | en_US |
dc.identifier.doi | 10.3390/curroncol29120781 | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0003-4065-4044 | en_US |
dc.identifier.orcid | 0000-0002-0463-0363 | en_US |
dc.identifier.orcid | 0000-0003-2487-5488 | en_US |
dc.identifier.orcid | 0000-0002-3528-4467 | en_US |
dc.identifier.orcid | 0000-0002-2530-0523 | en_US |
dc.identifier.orcid | 0000-0001-7319-8546 | en_US |
dc.identifier.orcid | 0000-0001-8659-5591 | en_US |
dc.identifier.orcid | 0000-0002-9317-9526 | en_US |
dc.identifier.orcid | 0000-0002-8948-9089 | en_US |
dc.identifier.orcid | 0000-0002-9770-2791 | en_US |
dc.identifier.orcid | 0000-0001-6123-1951 | en_US |
dc.identifier.orcid | 0000-0002-3448-5064 | en_US |
dc.identifier.orcid | 0000-0002-1664-2513 | en_US |
dc.identifier.pubmedid | 36547195 | - |
dc.description.volume | 29 | - |
dc.description.issue | 12 | - |
dc.description.startpage | 9928 | - |
dc.description.endpage | 9955 | - |
local.name.researcher | Gan, Hui K | |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Medical Oncology | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.